Microglia are the primary immune cells of the brain, but their role in Parkinson's disease is not fully understood. Chronic microglial activation is toxic to neurons, but in the early stages of pathology, microglia also exert beneficial functions. We used induced pluripotent stem cell (iPSC)-derived coculture models to...
Hung-Ju Chueh, Antigoni Katsikoudi, Ana Aragón-González et al.· Science Translational Medici...· 0 citations
Misfolded alpha-Synuclein (α-Syn) accumulation is the defining molecular pathology of Parkinson’s disease (PD), yet blood-based assays remain challenged by the high background of peripheral α-Syn originating mainly from red blood cells. Neuronal extracellular vesicles (EVs) circulating in blood offer a biologically enr...
Tian-Rui Chang, Cheng Jiang, Shi-Jun Yan et al.· Science Advances· 0 citations
The primary mechanism and subcellular localisation of α-synuclein toxicity in Parkinson’s disease pathogenesis remain unknown. We spatially and temporally resolved proteomic and transcriptomic changes in human iPSC-derived dopaminergic neurons with increasing burden of pathological α-synuclein. We found that misfolded...
Chor Lai Lam, N. Gatford, Ana Aragón-González et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.